Home › Metastatic Cancer › Massachusetts

Pag-aaral pangklinika para sa Metastatic Cancer sa Massachusetts

65 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Tufts Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Baystate Medical Center, Springfield
at 1 pa

Nagre-recruitPhase 2

Lahat ng edad · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Massachusetts General Hospital, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05372614

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Insitute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Brigham and Women's Hospital (BWH), Boston
Dana-Farber Cancer Institute (DFCI), Boston
Dana-Farber Brigham Cancer Center - Foxborough, Foxborough
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Dana Farber Cancer Institute., Boston

Nagre-recruitPhase 1/2

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Mass General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05118789

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Massachusetts General Hospital, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06302621

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Mass General Cancer Center, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06915753

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Massachusetts General Hospital, Boston
University of Massachusetts Medical School, Worcester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mass General Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
University of Massachusetts Medical School, Worcester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

University of Massachusetts Chan Medical School, Worcester

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213804

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Massachusetts General Hospital - Main Campus, Boston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07629960

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Brigham and Women's Hospital, Boston
Dana Farber/Mass General Brigham Cancer Care, Inc, Boston
Dana-Farber Cancer Institute - Chestnut Hill, Newton

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04585958

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Boston Medical Center, Boston
Lahey Hospital & Medical Center, Burlington

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06311214

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Boston

Nagre-recruitPhase 1/2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Massachusetts General Hospital, Boston

Nagre-recruitPhase 1/2

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT04802759

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Massachusetts General Hospital (MG), Boston

Nagre-recruitPhase 1

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06983743

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Avenzo Therapeutics Recruiting Site, Boston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07193511

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05687136

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Massachusetts General Hospital, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05687110

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 12 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT05372640

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Nagre-recruitPhase 1/2

Edad 12 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05533697

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT07137416

A Study of PYX-201 in Advanced Solid Tumors

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT05720117

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Exelixis Clinical Site #10, Boston
Exelixis Clinical Site #11, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT06952010

A Study of LY4175408 in Participants With Advanced Cancer

Massachusetts General Hospital, Boston

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.